-
Who we are
Who we are
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
Discover our scienceLearn about our validated protein-based nanoparticle and Matrix-M™ adjuvant technology.
-
What we do
What we do
Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships
Latest UpdatesStay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
Medical
Professionals Hub
Professionals Hub
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
Resources prepared for you to answer your questions
Publications
Source in-depth information about our research areas
Global authorization site of Novavax COVID-19 Vaccine (recombinant, adjuvanted)
Product summary for healthcare professionals, patient information, expiry date checker, FAQs, and more
Global medical information site
Ask medical questions, report adverse events, and report product quality complaints
Become a clinical trial site with Novavax
If you are interested in participating as a clinical trial site with Novavax, please complete the site questionnaire.